Ligand validation:5F19

BOG: octyl beta-D-glucopyranoside

BOG is a Ligand Of Interest in 5F19 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5F19_BOG_B_618	53%	73%	0.154	0.916	0.48	0.55	-	-	0	0	100%	1
5IKQ_BOG_A_601	65%	52%	0.11	0.91	1.16	0.7	1	-	0	0	100%	1
5IKR_BOG_A_608	28%	50%	0.189	0.839	1.18	0.78	1	-	0	0	100%	1
5F1A_BOG_B_608	24%	63%	0.205	0.834	0.49	0.93	-	2	2	0	100%	1
5IKV_BOG_A_612	22%	48%	0.204	0.82	1.13	0.87	1	1	2	0	100%	1
5B5S_BOG_A_301	99%	45%	0.045	0.983	0.92	1.19	1	1	0	0	100%	1
4KRG_BOG_A_503	99%	54%	0.048	0.981	1.11	0.69	2	-	1	0	100%	1
2OXL_BOG_B_101	96%	29%	0.064	0.97	1.1	1.71	2	5	1	1	100%	0.7
7VL5_BOG_A_801	93%	65%	0.072	0.967	0.73	0.63	-	-	0	0	100%	1
3MQE_BOG_A_704	90%	70%	0.073	0.955	0.55	0.6	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.